Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Boudreau

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Tropical Medicine and Hygiene|November 1, 1982
Evaluation of the antimalarial activity of the phenanthrenemethanol halofantrine (WR 171,669)T M Cosgriff, E F Boudreau, C L Pamplin, et al.
Clinical Pharmacology and Therapeutics|October 1, 1990
Mefloquine kinetics in cured and recrudescent patients with acute falciparum malaria and in healthy volunteersE F Boudreau, L Fleckenstein, L W Pang, et al.
The American Journal of Tropical Medicine and Hygiene|September 1, 1984
Evaluation of the 4-pyridinemethanol WR 180,409 (enpiroline) in the treatment of induced Plasmodium falciparum infections in healthy, non-immune subjectsT M Cosgriff, E F Boudreau, C L Pamplin, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1992
Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in ThailandG Watt, L Loesuttivibool, G D Shanks, et al.
Bulletin of the World Health Organization|January 1, 1988
Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in ThailandE F Boudreau, L W Pang, K E Dixon, et al.
Annals of Internal Medicine|February 15, 1994
Failure of doxycycline as a causal prophylactic agent against Plasmodium falciparum malaria in healthy nonimmune volunteersM J Shmuklarsky, E F Boudreau, L W Pang, et al.
Vaccine|February 24, 2006
Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccineM J Hepburn, M G Kortepeter, P R Pittman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Tropical Medicine and Hygiene|November 1, 1982
Evaluation of the antimalarial activity of the phenanthrenemethanol halofantrine (WR 171,669)T M Cosgriff, E F Boudreau, C L Pamplin, et al.
Clinical Pharmacology and Therapeutics|October 1, 1990
Mefloquine kinetics in cured and recrudescent patients with acute falciparum malaria and in healthy volunteersE F Boudreau, L Fleckenstein, L W Pang, et al.
The American Journal of Tropical Medicine and Hygiene|September 1, 1984
Evaluation of the 4-pyridinemethanol WR 180,409 (enpiroline) in the treatment of induced Plasmodium falciparum infections in healthy, non-immune subjectsT M Cosgriff, E F Boudreau, C L Pamplin, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1992
Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in ThailandG Watt, L Loesuttivibool, G D Shanks, et al.
Bulletin of the World Health Organization|January 1, 1988
Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in ThailandE F Boudreau, L W Pang, K E Dixon, et al.
Annals of Internal Medicine|February 15, 1994
Failure of doxycycline as a causal prophylactic agent against Plasmodium falciparum malaria in healthy nonimmune volunteersM J Shmuklarsky, E F Boudreau, L W Pang, et al.
Vaccine|February 24, 2006
Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccineM J Hepburn, M G Kortepeter, P R Pittman, et al.
Pageof 2